This product is an enzyme protein isolated from healthy human urine or obtained from human kidney tissue culture. It is composed of two parts with molecular weight of 33000 (LMW-Tchu-Pa) and 54000 (HMW-Tchu-Pa), respectively. This product directly acts on the endogenous fibrinolytic system, can catalyze the lysis of plasminogen plasminogen, which can not only degrade fibrin clots, but also degrade fibrinogen, coagulation factor and coagulation factor in the blood circulation, so as to play the role of thrombolysis. This product has quick and good effect on newly formed thrombus. This product can also improve blood vessel ADP enzyme activity, inhibit ADP induced platelet aggregation, prevent thrombosis. After intravenous infusion of this product, the activity of plasminase in the patient's body was significantly increased; Plasminase activity returned to its original level a few hours after discontinuation.

Rizhao Beida Biotechnology Co., Ltd is located in Rizhao City in Shandong Province, China. It is a enterprise specialized in the research, production and sale of  medical apparatus ,biochemical and pharmaceutical raw materials. The high quality, integrity and global marketing network enable our company to win high praise home and abroad including in Europe, America, Japan and Southeast Asia. 

With a wide range, good quality, reasonable prices and stylish designs, our products are extensively used in cosmetic and plastic surgery and other industries. We can also provide OEM and ODM service.We are looking forward to establishing a long-term business relationship with overseas in the near future based on mutual benefits.